Berger, M. D. (2018). A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationBerger, M. D. A Polymorphism Within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationBerger, M. D. A Polymorphism Within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.